ASSESSMENT OF GLEASON SYSTEM USE ON DIFFERENT TYPES OF PROSTATIC TISSUE SAMPLES

Similar documents
Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Supplemental Information

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

Although current American Cancer Society guidelines

A re-audit of Prostate biopsies from January to December 2010 and 2013.

R J M E Romanian Journal of Morphology & Embryology

Gleason Scoring System 2017 JASREMAN DHILLON, MD ASSOCIATE PROFESSOR, DEPARTMENT OF ANATOMIC PATHOLOGY, MOFFITT CANCER CENTER, TAMPA, FLORIDA

OMPRN Pathology Matters Meeting 2017

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Correlation between Gleason Scores in Needle Biopsy and Corresponding Radical Prostatectomy Specimens: A Twelve-Year Review

GUIDELINES ON PROSTATE CANCER

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

Prostatic ductal adenocarcinoma is a subtype of

Accurate prediction of the biological potential of. Correlation between the Gleason Scores of Needle Biopsies and Radical Prostatectomy Specimens

Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma

Diagnosis, pathology and prognosis including variant pathology

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Prostate Case Scenario 1

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

Introduction. Key Words: high-grade prostatic intraepithelial neoplasia, HGPIN, radical prostatectomy, prostate biopsy, insignificant prostate cancer

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

The Role of the Pathologist Active Surveillance for Prostate Cancer

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Grading Prostate Cancer: Recent Changes and Refinements

Prostate Overview Quiz

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

OPEN ACCESS ORIGINAL ARTICLE

Update on Reporting Prostate Cancer Pathology

Signet-Ring Cell Change in Benign Prostatic Hyperplasia - A Rare Case Report

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

ROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS

Study of High Grade Prostatic Intraepithelial Neoplasia for a Period of Five Years B. Rajashekar Reddy 1, Rameswarapu Suman Babu 2 and P.

Internationally indexed journal

Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

ANATOMICAL PATHOLOGY TARIFF

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Signet-Ring Cell Change in Benign Prostatic Hyperplasia - A Rare Case Report

Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer

Recommendations for the Reporting of Prostate Carcinoma

Cancer. Description. Section: Surgery Effective Date: October 15, 2016 Subsection: Original Policy Date: September 9, 2011 Subject:

Clinicopathological Spectrum of Prostatic Adenocarcinoma in 60 Patients

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

Efficacy of FNAC in early diagnosis of prostatic carcinoma

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Abstract. Introduction. Salah Abobaker Ali

MEDICAL POLICY Genetic and Protein Biomarkers for Diagnosis and Risk Assessment of

Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer

Human Papillomavirus Testing in Head and Neck Carcinomas

Definition of Synoptic Reporting

PDF of Trial CTRI Website URL -

According to the original drawing of D. F. Gleason,

GUIDELINEs ON PROSTATE CANCER

ISPUB.COM. Interpretation Of Prostatic Biopsies: A Review. A Chitale, S Khubchandani INTRODUCTION NON-NEOPLASTIC LESIONS GRADING: GLEASON'S SCORE

Pitfalls in the diagnosis of well-differentiated hepatocellular lesions

Prostate Cancer: 2010 Guidelines Update

AJCC Cancer Staging 8 th Edition. Prostate Chapter 58. Executive Committee, AJCC. Professor and Director, Duke Prostate Center

DOCTORAL THESIS SUMMARY

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

Prognostic value of the Gleason score in prostate cancer

The Impact of MRI-TRUS Cognitively Targeted Biopsy on the Incidence of Pathologic Upgrading After Radical Prostatectomy

Focal Therapy is a Fool s Paradise : The whole prostate must be treated!

Prostate Cancer Grading, Staging and Reporting: An Update Cristina Magi-Galluzzi, MD, PhD

Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy

Prostate Cancer Case Study 1. Medical Student Case-Based Learning

Case: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT

Stromal Fat Content of the Parathyroid Gland

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer

THE DILEMMA OF PROSTATE CANcer

STUDY OF PROSTATIC LESION FOR A PERIOD OF FIVE YEARS

Division of Oncology, S Orsola-Malpighi Hospital, Bologna, Italy. Department of Surgery, Cordoba University Medical School, Cordoba, Spain

The role of T2-weighted imaging in detecting prostate cancer of the central zone in 3T multiparametric magnetic resonance examination

Systems Pathology in Prostate Cancer

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Pathology of the Prostate. PathoBasic Tatjana Vlajnic

Outcomes Following Negative Prostate Biopsy for Patients with Persistent Disease after Radiotherapy for Prostate Cancer

Prostate Cancer Local or distant recurrence?

Quality ID #395: Lung Cancer Reporting (Biopsy/Cytology Specimens) National Quality Strategy Domain: Communication and Care Coordination

Update on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center

Asian J Androl 2005; 7 (2): DOI: /j x

DOCTORAL THESIS SUMMARY

Disease-specific death and metastasis do not occur in patients with Gleason score 6 at radical prostatectomy

MR-US Fusion Guided Biopsy: Is it fulfilling expectations?

Received: 11 Feb. 2013; Accepted: 7 Jun. 2013

Large blocks in prostate and bladder pathology

Accuracy of post-radiotherapy biopsy before salvage radical prostatectomy

Preoperative Gleason score, percent of positive prostate biopsies and PSA in predicting biochemical recurrence after radical prostatectomy

Instructions for Coding Grade for 2014+

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

JMSCR Vol 05 Issue 03 Page March 2017

Transcription:

ASSESSMENT OF GLEASON SYSTEM USE ON DIFFERENT TYPES OF PROSTATIC TISSUE SAMPLES I. E. PLEŞEA*, B. ZAHARIA*, S. D. ENACHE**, G. MITROI***, P. TOMESCU***, O. T. POP*, P. BADEA****, A. KOŻOKIĆ***** *Department of Pathology, University of Medicine and Pharmacy of Craiova; **Department of Pathology, Emergency County Hospital, Craiova; ***Department of Urology, University of Medicine and Pharmacy of Craiova; ****Department of Biostatistics, University of Medicine and Pharmacy of Craiova; *****City Hospital, Kladovo, Republic of Serbia and Montenegro Summary. One of the well-known and accepted methods of prostatic adenocarcinoma grading is Gleason system. The authors made a retrospective analysis of 221 prostatic adenocarcinomas divided into three groups (transvesical prostatectomies, transurethral resections and needle biopsies) following the type of surgical procedure used for drawing the tissue. Gleason scores and comparison between odd and even Gleason scores were assessed in the entire group and in each subgroup. High scores prevailed, meaning a tendency towards a low grade of differentiation. Even scores also prevailed meaning, on one hand, that, often, the examined specimen reveals only one pattern and, on the other hand, that surgical procedures as transurethral resections and unique needle biopsies cannot offer a sufficient material for examination, the multicentricity of prostatic carcinoma being well known. Key words: prostate, carcinoma, Gleason score. INTRODUCTION The Gleason system is one of the most internationally accepted and used methods for grading prostate cancer, due mainly to its marked prognostic value, being well correlated with the stage and metastatic potential (Mora et al., 2001; De la Taille et al., 2003; Shen et al 2003; Xiao et al., 2004; Humphrey, 2004). Prostatic adenocarcinoma often is multifocal, and different Gleason grades may be present in different foci. The Gleason grading system uniquely combines data from different areas of carcinoma in the same prostate specimen (Arora et al., 2004). This grading system, proposed by Gleason in 1977, is based only on architectural criteria, i.e. the type of tumor glandular appearance as identified on a relatively small magnification. In contrast to other systems used for histological grading of prostate carcinoma, this one does not use the cytological aspect as grading criterion. Grading criteria are very precisely defined (Gleason, 1977). The variety of histopathologic features on the same sample is surpassed by: establishing a primary grade, assigned to the histological aspect that represents the greatest area of the fragment. MORPHOL. EMBRYOL., 1999 2004, XLV, p. 25 34

26 I. E. Pleşea et al. establishing a secondary grade for the histological aspect that represents the second area in terms of extention. Both the primary architectural pattern (dominant pattern) and the secondary one (second in terms of spreading) are identified and are assigned a grade from 1 to 5, which means: (1) very well differentiated; (2) well differentiated; (3) moderately differentiated; (4) poorly differentiated and (5) very poorly differentiated (Gleason, 1977). Clarifying the histologic criteria for distinguishing each grade, especially between Gleason grades 2 and 3, is important for accurate grading (Fukagai et al., 2001). The primary and secondary patterns are combined to give a tumor score, referred to as Gleason score or sum (Rubin et al., 2000). Gleason combined scores are between 2 (1+1=2), which represents a tumor, composed of uniformly disposed Gleason 1 pattern and 10 (5+5=10), which represents an entirely undifferentiated tumor. If the tumor presents only one histological pattern or if only a minute focus of tumor is present on biopsy, in order to obtain uniformity, both primary and secondary scores are assigned the same rang respectively the Gleason score is assigned by doubling the Gleason pattern (Rubin et al., 2000). When more patterns are present, identifying the two dominant patterns may prove to be difficult. The main advantage of Gleason system is that it is based only on morphological criteria. Gleason score is well correlated with other prognostic factors such as the size of the tumor, the presence of metastases in the pelvic lymph nodes and PSA level (Mora et al., 2001; De la Taille et al., 2003; Shen et al., 2003; Xiao et al., 2004; Humphrey, 2004). A frequent problem in using Gleason system is distinguishing Gleason score 6 from 7 especially among biopsy specimens with lower tumor volumes, particularly among those with less than 30% involvement (Coard and Freeman, 2004). The major deficiency of the Gleason system is that, even if both low grades (2 4 combined) and high grades (8 10 combined) have a pretty accurate predictive capacity, in most patients with medium degree tumors the prognostic is uncertain. In our laboratory, the pathologist could examine three kinds of prostatic tissue samples: specimens proceeding from transvesical prostatectomy, performed for benign nodular hyperplasia (BNH); specimens proceeding from transurethral resection, performed mainly also for BNH; ultrasound guided biopsies performed mainly for suspicion of prostatic carcinoma. Therefore we intended to make an assessment of the way that Gleason system is applied to each of these three categories of specimens and to the entire group of diagnosed prostatic carcinomas. MATERIAL AND METHODS A retrospective review of 221 prostate specimens from patients hospitalised in the Urology Department of Craiova Emergency County Hospital between 1992

Gleason system use on different types of prostatic tissue samples 27 and 1999 in which a diagnosis of adenocarcinoma was made in the Pathology Department of the same hospital was conducted. Using the type of surgical procedure performed for each patient as a distribution criterion, the selected cases were divided into three groups as follows: group 1: transvesical prostatectomies (TVP) for BNH 33 cases; group 2: transurethral resections (TUR) 82 cases; group 3: prostatic needle biopsies (B) 106 cases. Histopathological slides and paraffin blocks of each case represented the materials from the Pathology Department archives. The stain technique used in all cases was haematoxylin-eosin. The algorithm of study was the following: assessment of Gleason scores in the entire group and in each subgroup and comparison between odd and even Gleason scores in the entire group and in each subgroup. RESULTS AND COMMENTS ASSESMENT OF GLEASON SCORES IN THE ENTIRE GROUP Gleason score analysis showed that tumoral proliferations were mostly labelled as score 6 This score was followed, in a decreasing occurring scale by scores 8, 9 and 10 (Figure 1). No. of Cases 55 50 45 40 35 30 25 20 15 10 5 0 55 51 32 26 29 12 11 1 4 2 3 4 5 6 7 8 9 10 Gleason Score Figure 1 Gleason scores distribution in the entire group Score 2 Gleason score 2 was established only in one case in which, one of the transurethral resection specimens showed a small nodule composed of glands

28 I. E. Pleşea et al. resembling normal ones but with compact disposition and slightly delimited from the rest of the hyperplastic prostatic tissue (Figure 2). Score 3 This score was established in 4 cases in which pattern 1 and pattern 2 were also present on the samples that were examined. In two of these cases the dominant pattern was pattern 1 and in the remaining two cases the dominant pattern was pattern 2. Score 4 This score was established in 12 cases after multiplying by 2 the index of the single pattern observed on the examined samples (Figure 3). Score 5 In the 11 cases with Gleason score 5 there could be seen only combinations of patterns 2 and 3. In 7 cases the dominant pattern was pattern 2 while in the other 4 cases the dominant pattern was pattern 3. Pattern 3 was usually a type a pattern (7 cases). Score 6 Score 6 was established in 55 cases. All 55 cases were combinations of the different subtypes of pattern 3 alone (Figure 4, a and b). In 5 cases the subtype of pattern 3 was not mentioned. In 32 cases only one subtype was identified: in 4 cases there was only subtype a ; in 17 cases only subtype b and in 11 cases only subtype c. 18 cases were combinations of pattern 3 subtypes as follows: 2 cases with subtypes a + b ; 3 cases with subtypes a + c ; 10 cases with subtypes b + c and 3 cases in which the combination was c + b. Score 7 This score was established in 26 cases. There were 25 cases with combinations between patterns 3 and 4 (Figure 5) as follows: 18 cases with pattern 3 as the dominant pattern and 7 cases with pattern 4 as the dominant pattern. Pattern 3 was usually of type b and pattern 4 was mostly of type a. Score 8 Score 8 was established in 51 cases. 35 of them were combinations only between different subtypes of pattern 4 (Figure 6, a and b). Score 9 32 cases were assigned a score 9 as a combination between patterns 4 and 5. Pattern 4 was the dominant one in 19 cases and mostly of a type while pattern 5 was the dominant one in the other 13 cases, and mostly of b type.

Gleason system use on different types of prostatic tissue samples 29 Score 10 A score 10 was established in 29 cases and only as a combination between different subtypes of pattern 5. In 26 cases, there was only one subtype, as follows: 6 cases with subtype a (Figure 7a) and the other 19 cases with subtype b (Figure 7b). The remaining 4 cases were combinations of subtypes a + b. DIFFERENCE BETWEEN DOMINANT AND SECONDARY PATTERNS There were only 17 out of all the 221 studied cases with a somewhat more unusual situation consisting of a difference between the dominant pattern and the secondary one >1. In one case from the score 7 group, the grade was determined by the association of patterns 5 and 2, the dominant one being pattern 5. The others 16 cases were assigned a score 8, being combinations between patterns 3 and 5. In 9 cases the dominant pattern was 3 and, in the other 7 cases, 5 respectively. Pattern 3 was mostly of type b, followed by type c. In most cases pattern 5 was of type b. In his study on 2911 cases of prostate carcinoma, Gleason found that in 505 cases the difference between the dominant pattern and the secondary one was 2 and only 3 cases with a difference of at least 3 (Gleason, 1977) (Table 1). The difference between the two studies was confirmed by the value of 13.78 of (2 2) χ 2 test, considered as significant. Study Table 1 The rate of cases with difference between dominant and secondary pattern >1 Difference >1 No. of cases The whole group Craiova 17 221 7.7 Gleason 508 2911 17.5 Difference between dominant and secondary patterns may be significant if the Gleason score is converted to 1 2 3 system. When, after conversion, the tumor is placed in the moderately differentiated category but the dominant pattern was one equivalent with poor differentiation, the risk of undergrading the tumor aggressiveness using the Gleason score is present. In our study group this situation was seen in only one case, with Gleason score 7 and pattern 5 as the dominant one. On the contrary, in all the other 16 cases we could say that the score (i.e., 8 ) placed the tumor in a group that was closer to its aspect and behaviour although the dominant pattern ( 3 ) was one characterising better differentiated tumors. ASSESMENT OF GLEASON SCORES IN INDIVIDUAL GROUPS Group 1 (TVP) In the group with transvesical prostatectomy, the most frequent cases were those with score 6, followed by score 9 and 8 (Table 2). %

30 I. E. Pleşea et al. Group 2 (TUR) In the group with transurethral resection, the different scores were more heterogenously distributed. Thus, the most frequent score was 8, followed by scores 6, 10 and 7 (Table 2). Group 3 (B) In the group III (with ultrasound guided single biopsy), score 6 was again the most frequent one and was followed by those indicating a poorly differentiated cancer such as 8, 10 and 9 (Table 2). Table 2 Gleason scores distribution in the three study groups Subtype Gleason Score (No. of cases) Total 2 3 4 5 6 7 8 9 10 I (TVP) 33 0 3 1 3 8 5 6 7 0 II (TUR) 82 1 1 6 6 16 11 20 9 12 III (B) 106 0 0 5 2 31 10 25 16 17 B 2 4,7 29,3 9,4 23,6 15 16 1,2 TUR 7,3 7,3 19,5 13,4 24,4 11 14,7 1,2 TVP 9 3 9 24,3 15,2 18,2 21,3 Entire Group 2 5,5 5 25 12 23 14 13 0 10 20 30 40 50 60 70 80 90 100 Gl 2 Gl 3 Gl 4 Gl 5 Gl 6 Gl 7 Gl 8 Gl 9 Gl 10 Figure 8 Gleason scores rates in the three studied groups Comparing the score distribution in the three groups we could observe a relatively homogenous distribution (excepting the lack of score 10 ) in TVP group, with large specimens and, therefore, large amounts of tumoral tissue. The rates of low scores ( 2 4 ) are decreasing parallel with the amount of drawn tissue from group 1 (TVP) to group 3 (B) whereas high scores ( 8 10 ) rates are conversely increasing. This different score distribution in the three groups was confirmed by the statistic analysis using (3 9) χ 2 test, which revealed, for the given data, a value of 28.58, considered as significant (Figure 8).

Gleason system use on different types of prostatic tissue samples 31 COMPARISON BETWEEN ODD AND EVEN SCORES We also calculated the sum of odd and even scores for each group and for the entire group and then compared the results (Table 3, Figure 9). Score Table 3 Odd and Even scores distribution in studied groups I (TVP) II (TUR) III (B) Entire Group Cases % Cases % Cases % Cases % G3+G5+G7+G9 18 54.5 27 32.9 28 26.4 73 33 G2+G4+G6+G8+G10 15 45.5 55 67.1 78 73.6 148 67 Cases (No. / %) 33 100 82 100 106 100 221 100 Group I (TVP) The sums of odd and even scores showed that, in this group, there is a prevalence of odd scores (Table 3). Another important observation is that, of the 6 cases assigned as score 8, three showed a difference between the dominant score and the secondary one >1. The amount of prostatic tissue, offered by these large samples, allowed a better evaluation of a greater area of the tumor, which led to a more frequent finding of both a dominant and secondary different patterns. Thus, the score could be established on more than one pattern (Figure 5). Group II (TUR) In this group, the same sums show a clear prevalence of the even scores (Table 2). It should also be mentioned that, of the 20 cases that were assigned a score 8, five showed a difference between the dominant score and the secondary one >1, with pattern 3 as the dominant one. In the remaining cases, the even scores were obtained by doubling the index of the only pattern seen on the studied samples. Group III In this group, the sums of odd and even scores show a clear prevalence of the even ones (Table 2). This is a consequence of the fact that on biopsy materials different patterns of the intraprostatic proliferation are very rarely observed, especially if the proliferation is also multicentric. We saw also that only 3 out of the 25 cases that were assigned a pattern 8 showed a difference between the dominant pattern and the secondary one >1, with pattern 3 as the dominant one. Figure 9 clearly reveals the prominent decrease of odd scores from group 1 (TVP) to group 3 (B). This trend was outlined also by the statistic analysis using (2 3) χ 2 test whose obtained value of 9 was considered as significant.

32 I. E. Pleşea et al. Entire Group 33 67 B 26,4 73,6 TUR 32,9 67,1 TVP 54,5 45,5 0 10 20 30 40 50 60 70 80 90 100 Odd Scores Even Scores Figure 9 Odd and Even scores rates in studied groups FINAL COMMENTS The analysis of Gleason scores showed that, through the overall most frequent score was 6, meaning a moderately differentiated malignant proliferation, high scores (from 8 to 10 ), together, were seen in half of the all cases, meaning an increased prevalence of low differentiated and aggressive cancers. Moreover, the important group of carcinomas discovered on TUR specimens (82 cases), from which 63.4%, i.e. 52 cases, had a score 7 is another argument sustaining the aggressiveness of these tumors which widely invaded the prostatic parenchyma, till the anterior periurethral areas. Even scores are, usually the result of a sum between the same types of patterns. The high prevalence of these scores in our study (more than two thirds of cases) meant, on one hand, the discovery, in most of the cases, of a single pattern on the tissue sample, the score being obtained by doubling the pattern index. This was, without any doubt, the consequence of the great number of cases in the groups 2 (TUR) and 3 (B), with small amounts of prostatic tissue where it is most likely to find the same type of architectural arrangement of tumoral glands or cells. On the other hand, the high prevalence of even scores could be the result of an insufficient interception of tumoral tissue by drawing procedures such us transurethral resection, which could intercept the peripheral areas of the malignant proliferation, or the unique needle biopsies. Our data are concordant with those from other studies and support the idea of a more aggressive investigation for detecting the prostatic cancer in its intraprostatic stage, emphasizing the usefulness of a multiple-core needle biopsy.

Gleason system use on different types of prostatic tissue samples 33 Thus, recent studies concluded that, when only a minute focus of tumor is present on biopsy, the Gleason score is assigned by doubling the Gleason pattern and, consequently, the assigned Gleason score could not predict tumor stage, Gleason grading remaining, in these cases a poor predictor of pathological outcome (Lattouf and Saad, 2002; Rubin et al., 2000). Therefore, an extended (18 or 12-gauge rather than six-core) prostate needle biopsy strategy for TRUS-guided biopsy of the prostate gland improves detection and histologic grading and provides better guidance to determine the appropriate treatment in patients with prostate carcinoma (Shen et al., 2003; San Francisco et al., 2003; O Connell et al., 2004). The prominent frequency of high grade carcinomas among the studied cases could be an argument for sustaining the introduction, in our country, of PSA serum level determination as a screening test, in order to trace out the early stages of prostatic cancer and guide further the ultrasound examination and multicore needle biopsies, being well known that the Gleason histological grading of prostate carcinoma is positively related to the serum PSA level (Xiao et al., 2004). CONCLUSIONS In conclusion, we can say that, in the studied groups, high scores prevailed, showing tumors with a marked tendency towards a low grade of differentiation and high grade of aggressiveness. Prevalence of even scores meant that, with only few exceptions, there was only one architectural pattern on the studied samples, due to the large number of cases with transurethral resection and unique needle biopsies, which could offer no sufficient information about the real status of the prostatic malignant proliferation. REFERENCES ARORA R., KOCH M.O., EBLE J.N. et al., Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate, Cancer, 2004, 100(11):2362 2366. COARD K.C., FREEMAN V.L., Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies, Am J Clin Pathol, 2004, 122(3):373 376. DE LA TAILLE A., VIELLEFOND A., BERGER N. et al., Evaluation of the interobserver reproducibility of Gleason grading of prostatic adenocarcinoma using tissue microarrays, Hum Pathol, 2003, 34(5):444 449. FUKAGAI T., NAMIKI T., NAMIKI H. et al., Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens, Pathol Int, 2001, 51(5):364 370. HUMPHREY P.A., Gleason grading and prognostic factors in carcinoma of the prostate, Mod Pathol, 2004, 17(3):292 306. LATTOUF J.B., SAAD F., Gleason score on biopsy: is it reliable for predicting the final grade on pathology?, BJU Int, 2002, 90(7):694 698, discussion 698 699. MORA L.B., BUETTNER R., AHMAD N. et al., Prostate adenocarcinoma: cellular and molecular abnormalities, Cancer Control - JMCC, 2001, 8(6):551 561.

34 I. E. Pleşea et al. O'CONNELL M.J., SMITH C.S., FITZPATRICK P.E. et al., Transrectal ultrasound-guided biopsy of the prostate gland: value of 12 versus 6 cores, Abdom Imaging, 2004, 29(1):132 136. RUBIN M.A., DUNN R., KAMBHAM N. et al., Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?, Am J Surg Pathol, 2000, 24(12):1634 1640. SAN FRANCISCO I.F., DEWOLF W.C., ROSEN S. et al., Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy, J Urol, 2003, 169(1):136 140. SHEN B.Y., TSUI K.H., CHANG P.L. et al., Correlation between the Gleason scores of needle biopsies and radical prostatectomy specimens, Chang Gung Med J, 2003, 26(12):919 924. XIAO Q., YIN H., LU Z. et al., Gleason histologic grading of prostate carcinoma in relation to serum PSA, PSA in situ and immunohistochemical expression of 34 beta E12 and P504S, Zhonghua Nan Ke Xue, 2004, 10(5):362 365. Acknowledgements. The study was part of the Grant C.N.C.S.I.S code D107/2000, financed by Romanian Government and World Bank. Received: 16 April, 2004 Accepted: 10 September, 2004

Figure 2 Gleason Score 2, TUR specimen Figure 4 a) Gleason Score 6 3a (up) + 3b (down), TVP specimen Figure 3 Gleason Score 4, TUR specimen Figure 5 Gleason Score 7 (3c + 4a), TVP specimen Figure 4 b) Gleason Score 6 3a + 3a, B specimen

Figure 6 a) Gleason Score 8 (4a + 4a), TVP specimen Figure 6 b) Gleason Score 8 (4b + 4b), TUR specimen Figure 7 a) Gleason 10 (5a + 5a), TUR specimen Figure 7 b) Gleason Score 10 (5b + 5b), TVP specimen